These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38929588)
41. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote. Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858 [TBL] [Abstract][Full Text] [Related]
42. Comparison of remimazolam and propofol about safety outcome indicators during general anesthesia in surgical patients: a systematic review and meta-analysis. Wu X; Wang C; Gao H; Bai X; Zhang Z; Chen R; Huang X; An L; Yi J; Tong R Minerva Anestesiol; 2023 Jun; 89(6):553-564. PubMed ID: 36852570 [TBL] [Abstract][Full Text] [Related]
43. Remimazolam for sedation and anesthesia in children: A scoping review. Kuklin V; Hansen TG Acta Anaesthesiol Scand; 2024 Aug; 68(7):862-870. PubMed ID: 38722151 [TBL] [Abstract][Full Text] [Related]
44. Severe Anaphylaxis From Remimazolam in a Mastocytosis Cancer Patient: A Case Report. Mani J; Strang A; Faruki AA; Siddiqui ZA; Mena G Cureus; 2024 Sep; 16(9):e69079. PubMed ID: 39391444 [TBL] [Abstract][Full Text] [Related]
45. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study. Chae D; Kim HC; Song Y; Choi YS; Han DW Br J Anaesth; 2022 Jul; 129(1):49-57. PubMed ID: 35562226 [TBL] [Abstract][Full Text] [Related]
46. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia. Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598 [TBL] [Abstract][Full Text] [Related]
47. Remimazolam: An Updated Review of a New Sedative and Anaesthetic. Hu Q; Liu X; Wen C; Li D; Lei X Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859 [TBL] [Abstract][Full Text] [Related]
48. Remimazolam: A Retrospective Study of Initial Safety and Recovery Data in Diverse Procedural Sedation. Johnson KL; Meyers JS; Mortensen GN; Steege JR; Mara KC; Brinkman NJ Clin Ther; 2024 Feb; 46(2):90-95. PubMed ID: 38071132 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655 [TBL] [Abstract][Full Text] [Related]
50. Comparison of the recovery time of remimazolam besylate and propofol for gastrointestinal endoscopy sedation in elderly patients. Chen HY; Wang XX; Lu YG; Tang SH; Ding T; Song JC; Chen G Int J Med Sci; 2024; 21(7):1250-1256. PubMed ID: 38818475 [No Abstract] [Full Text] [Related]
51. Remimazolam versus propofol for deep sedation/anaesthesia in upper gastrointestinal endoscopy in elderly patients: A multicenter, randomized controlled trial. Lu K; Wei S; Ling W; Wei Y; Ran X; Huang H; Wang M; Wei N; Liao Y; Qin Z; Pan M; Wei Q; Fu L; Xiong B; Ma C; Jiang J; Huang Y J Clin Pharm Ther; 2022 Dec; 47(12):2230-2236. PubMed ID: 36334013 [TBL] [Abstract][Full Text] [Related]
52. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512 [TBL] [Abstract][Full Text] [Related]
53. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double-blind, controlled trial. Liu T; Lai T; Chen J; Lu Y; He F; Chen Y; Xie Y Pharmacol Res Perspect; 2021 Oct; 9(5):e00851. PubMed ID: 34390228 [TBL] [Abstract][Full Text] [Related]
54. Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review. Sneyd JR; Gambus PL; Rigby-Jones AE Br J Anaesth; 2021 Jul; 127(1):41-55. PubMed ID: 33965206 [TBL] [Abstract][Full Text] [Related]
56. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841 [TBL] [Abstract][Full Text] [Related]
57. Remimazolam: A Novel Option for Procedural Sedation in High Risk Patients. Pantos MM; Kennedy DR; Nemec EC J Pharm Pract; 2023 Feb; 36(1):149-154. PubMed ID: 34155946 [TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Dai G; Pei L; Duan F; Liao M; Zhang Y; Zhu M; Zhao Z; Zhang X Minerva Anestesiol; 2021 Oct; 87(10):1073-1079. PubMed ID: 34263581 [TBL] [Abstract][Full Text] [Related]
59. Remimazolam (Byfavo) for short-term procedural sedation. Med Lett Drugs Ther; 2022 Feb; 64(1644):26-28. PubMed ID: 35171895 [No Abstract] [Full Text] [Related]
60. The Role of Remimazolam in Neurosurgery and in Patients With Neurological Diseases: A Narrative Review. Teixeira MT; Brinkman NJ; Pasternak JJ; Abcejo AS J Neurosurg Anesthesiol; 2024 Jan; 36(1):11-19. PubMed ID: 37264540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]